• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

ACT:US

214.8500 USD 0.0900 0.04%

As of 20:04:02 ET on 07/29/2014.

Snapshot for Actavis plc (ACT)

Open: 214.8700 Day's Range: 213.3210 - 215.9600 Volume: 1,617,211
Previous Close: 214.9400 52wk Range: 130.0615 - 230.7700 1-Yr Rtn: +78.71%

Stock Chart for ACT

No chart data available.
  • ACT:US 214.8500
  • 1D
  • 1M
  • 1Y
214.9400
Interactive ACT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACT

Current P/E Ratio (ttm) 77.8838
Estimated P/E(12/2014) 15.4724
Relative P/E vs. SPX 4.3318
Earnings Per Share (USD) (ttm) 2.7586
Est. EPS (USD) (12/2014) 13.8860
Est. PEG Ratio 1.0769
Market Cap (M USD) 56,951.47
Shares Outstanding (M) 265.08
30 Day Average Volume 2,336,691
Price/Book (mrq) 3.8931
Price/Sale (ttm) 3.4912
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACT

Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.

Paul M BisaroChairmanBrenton L Saunders "Brent"President/CEO
R Todd JoyceChief Financial OfficerRobert A Stewart "Bob"Chief Operating Officer
More Company Profile & Key Executives for ACT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil